Alisa S Wolberg Selected Research

Factor XIII (Coagulation Factor XIII)

1/2022	Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.
12/2021	Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.
1/2020	The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
1/2020	Factor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in mice.
11/2019	Mechanistic rationale for factor XIII cotreatment in haemophilia.
12/2018	State of the art in factor XIII laboratory assessment.
1/2018	Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.
1/2018	Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition.
6/2016	Newly-Recognized Roles of Factor XIII in Thrombosis.
8/2014	Factor XIII activity mediates red blood cell retention in venous thrombi.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alisa S Wolberg Research Topics

Disease

43	Thrombosis (Thrombus) 01/2022 - 04/2003
24	Hemorrhage 01/2022 - 06/2004
12	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 04/2003
9	Hemophilia A (Haemophilia) 03/2021 - 03/2007
7	COVID-19 01/2022 - 01/2020
7	Inflammation (Inflammations) 01/2020 - 11/2009
6	Neoplasms (Cancer) 11/2019 - 06/2012
5	Venous Thromboembolism 01/2022 - 03/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 05/2011
4	Thrombophilia 10/2013 - 01/2004
3	Vascular System Injuries 09/2012 - 05/2008
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 06/2007 - 01/2004
2	Sepsis (Septicemia) 05/2021 - 01/2021
2	Obesity 03/2021 - 01/2020
2	Infections 04/2019 - 09/2012
2	Wounds and Injuries (Trauma) 05/2008 - 06/2004
1	Peritonitis 01/2022
1	Angioedema 03/2021
1	Postpartum Hemorrhage 01/2021
1	Ischemic Stroke 12/2020
1	Stroke (Strokes) 12/2020
1	Common Variable Immunodeficiency 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 11/2019
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2019
1	Factor XIII Deficiency 12/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Hyperprothrombinemia 01/2017
1	Activated Protein C Resistance (APC Resistance) 01/2017
1	Adenocarcinoma 05/2016
1	Sickle Cell Anemia (Hemoglobin S Disease) 11/2015

Drug/Important Bio-Agent (IBA)

30	FibrinIBA 01/2022 - 04/2003
18	Fibrinogen (Factor I)FDA Link 01/2022 - 05/2011
14	Thrombin FDA Link 01/2022 - 05/2007
10	Factor XIII (Coagulation Factor XIII)IBA 01/2022 - 08/2014
9	Thromboplastin (Tissue Factor)IBA 05/2021 - 01/2004
7	Hemostatics (Antihemorrhagics)IBA 01/2022 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2008
6	Fibrinolysin FDA Link 05/2021 - 09/2012
6	recombinant FVIIa (rFVIIa)FDA Link 07/2018 - 12/2005
4	estropipate (Ogen)FDA LinkGeneric 01/2022 - 09/2012
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2009
4	Factor VIIa (Activated Factor VII)IBA 07/2018 - 12/2005
4	Prothrombin (Factor II)IBA 08/2013 - 04/2003
3	AnticoagulantsIBA 01/2022 - 10/2014
3	fibrin fragment D (D-dimer)IBA 05/2021 - 01/2020
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2021 - 03/2007
3	ferric chlorideIBA 01/2020 - 05/2011
3	TransglutaminasesIBA 11/2015 - 08/2014
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 07/2015
2	Tranexamic Acid (AMCA)FDA Link 01/2021 - 01/2021
2	ThrombomodulinIBA 01/2021 - 01/2021
2	Blood Coagulation Factors (Coagulation Factor)IBA 11/2019 - 11/2015
2	AntigensIBA 12/2018 - 01/2018
2	Blood Group Antigens (Blood Groups)IBA 01/2017 - 01/2015
2	IntegrinsIBA 05/2016 - 10/2014
2	EnzymesIBA 01/2015 - 06/2004
2	AntibodiesIBA 12/2008 - 06/2007
2	Factor Xa (Coagulation Factor Xa)IBA 07/2007 - 03/2007
2	AutoantibodiesIBA 06/2007 - 10/2004
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	ibrutinibIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 05/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2021
1	Endothelial Protein C ReceptorIBA 01/2021
1	Kallikreins (Kallikrein)IBA 01/2021
1	KininsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2020
1	Biological ProductsIBA 11/2020
1	SilverIBA 10/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Everolimus FDA Link 01/2020
1	Peptides (Polypeptides)IBA 11/2019
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Amyloid (Amyloid Fibrils)IBA 11/2019
1	Transforming Growth Factor-beta Type II ReceptorIBA 11/2019
1	AntagomirsIBA 11/2019
1	MicroRNAs (MicroRNA)IBA 11/2019
1	Blood Proteins (Serum Proteins)IBA 04/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2018
1	Factor XIIIaIBA 01/2018
1	Hormones (Hormone)IBA 01/2017
1	CollagenIBA 01/2017
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2016
1	AntithrombinsIBA 03/2016
1	hemoglobin AAIBA 11/2015
1	Indicators and Reagents (Reagents)IBA 07/2015
1	Oral ContraceptivesIBA 01/2015
1	CystamineIBA 01/2015
1	factor V LeidenIBA 01/2015

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2004
2	Ligation 12/2021 - 08/2013
1	Lasers (Laser) 01/2022
1	Punctures 01/2018
1	Tonsillectomy 01/2018